SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPollen Street Regulatory News (POLN)

Share Price Information for Pollen Street (POLN)

Share Price is delayed by 15 minutes
Get Live Data
867.00    15.00 (1.76%)
Bid:
867.00
Ask:
873.00
Spread: 6.00 (0.692%)
Market Cap: £515.62m
POLN Live PriceLast checked at - London Stock Exchange

Intraday Pollen Street Share Chart

Q1 2026 Trading Update

7 May 2026 07:00

RNS Number : 3122D
Pollen Street Group Limited
07 May 2026
Β 

7 May 2026

Pollen Street Group Limited: Q1 2026 Trading Update

Pollen Street Group Limited ("Pollen Street", together with its subsidiaries, the "Group") is pleased to publish its trading update for the quarter ended 31 March 2026.

Total AuM

Β·

Total AuM increased by Β£1.1 billion during the quarter, to Β£8.2 billion as of 31 March 2026 reflecting strong fundraising in Private Credit IV ahead of its final close.

Β·

Total AuM as of 31 March 2026 comprised Β£4.2 billion in Private Equity and Β£4.0 billion in Private Credit.

Β·

Private Credit IV held its final close in April at Β£2.5 billion, significantly exceeding the initial target. Following the final close, total AuM stood at Β£8.4 billion.

Fee-Paying AuM

Β·

Fee-paying AuM ("FP AuM") increased Β£0.2 billion to Β£5.4 billion as of 31 March 2026.

Β·

Private Equity FP AuM remained at Β£3.1 billion and Private Credit FP AuM grew to Β£2.3 billion, reflecting Β£0.2 billion of net deployment during the period.

Β·

At the quarter end, the Group had Β£1.7 billion of undeployed committed capital across Private Credit funds, which will become fee-paying as it is deployed over time.

Full year FY26 expectations for Net Investment Return for the Investment Company remain unchanged, notwithstanding volatile market conditions during the quarter.

About Pollen Street

Pollen Street is an alternative asset manager dedicated to investing within the financial and business services sectors across both Private Equity and Private Credit strategies. The business was founded in 2013 and has consistently delivered top tier returns alongside growing AuM.

Β 

Pollen Street benefits from a complementary set of asset management activities focused on managing third-party AuM (the "Asset Manager") together with on-balance sheet investments (the "Investment Company").

Β 

The Asset Manager raises capital from high quality investors and deploys it into its Private Equity and Private Credit strategies. The strong recurring revenues from this business enable delivery of scalable growth.

Β 

The Investment Company invests in the strategies of the group delivering attractive risk adjusted returns and accelerating growth in third-party AuM of the Asset Manager through investing in Pollen Street funds, taking advantage of attractive investment opportunities and aligning interest with our investors to grow AuM. Today the portfolio is largely invested in credit assets with the allocation to Private Equity expected to increase to 30 per cent in the long term. The portfolio consists of both direct investments and investments in funds managed by Pollen Street.

Β 

POLN is listed on the London Stock Exchange (ticker symbol: POLN) and is a member of the FTSE 250 index. Further details are available at www.pollenstreetgroup.com.

Β 

For further information about this announcement please contact:

Β 

Pollen Street - Corporate Development Director

Shweta Chugh

+44 (0)20 3965 5081

Β 

Barclays Bank plc - Joint Broker

Neal West

+44 (0)20 7623 2323

Β 

Investec Bank plc - Joint Broker

Ben Griffiths / Kamalini Hull

+44 (0)20 7597 4000

Β 

FGS Global

Chris Sibbald / Anna Tabor

PollenStreetCapital-LON@fgsglobal.com

Β 

LEI: 894500LP94M98N8CY487

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTUNSNRNVUVRAR
Date   Source Headline
1st Jun 20263:01 pmRNSTotal Voting Rights
27th May 20264:46 pmRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
11th May 20265:39 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSQ1 2026 Trading Update
6th May 20264:40 pmRNSDirector/PDMR Shareholding
1st May 20269:49 amRNSTotal Voting Rights
1st May 20268:12 amRNSResult of AGM
28th Apr 20264:31 pmRNSDirector/PDMR Shareholding
16th Apr 20265:31 pmRNSInvestor Presentation via Investor Meet Company
14th Apr 20267:00 amRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
27th Mar 202610:36 amRNSDirector/PDMR Shareholding
26th Mar 20264:37 pmRNSDirector/PDMR Shareholding
26th Mar 20267:30 amRNSDividend Declaration
26th Mar 20267:00 amRNSFull Year 2025 Trading Update
2nd Mar 202611:26 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20261:57 pmRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20264:32 pmRNSDirector/PDMR Shareholding
2nd Feb 20263:12 pmRNSTotal Voting Rights
30th Jan 202610:59 amRNSDirectorate changes
28th Jan 202611:37 amRNSDirector/PDMR Shareholding
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSDirectorate change
23rd Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
30th Dec 20254:27 pmRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20259:50 amRNSUpdate Statement on 2025 AGM Voting Results
1st Dec 202511:15 amRNSTotal Voting Rights
28th Nov 20256:23 pmRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSQ3 2025 Trading Update
17th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSAnnouncement of New Share Buyback Programme
16th Oct 20256:16 pmRNSHolding(s) in Company
3rd Oct 202511:32 amRNSDirector/PDMR Shareholding
1st Oct 20255:12 pmRNSDirector/PDMR Shareholding
30th Sep 20254:07 pmRNSInvestor Presentation via Investor Meet Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.